FDA Biosimilar Policy: More Questions, More Answers

Law360, New York ( May 27, 2015, 11:48 AM EDT) -- On May 13, 2015, the U.S. Food and Drug Administration released yet another biosimilar Q&A guidance document — Biosimilars: Additional Questions and Answers Regarding Implementation of the Biologics Price Competition and Innovation Act of 2009. This draft guidance arrives on the heels of the April 28 release of three final biosimilar guidance documents, which also included a Q&A regarding implementation of the BPCI Act of 2009....

Law360 is on it, so you are, too.

A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.


A Law360 subscription includes features such as

  • Daily newsletters
  • Expert analysis
  • Mobile app
  • Advanced search
  • Judge information
  • Real-time alerts
  • 450K+ searchable archived articles

And more!

Experience Law360 today with a free 7-day trial.

Start Free Trial

Already a subscriber? Click here to login

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!